Marker Therapeutics Inc (MRKR)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current MRKR market cap is 15.97M. The company's latest EPS is USD -0.9231 and P/E is -1.94.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 258k | 1.06M | 1.24M | 1.17M | 1.93M |
| Operating Income | -3.2M | -2.94M | -2.55M | -2.31M | -2.4M |
| Net Income | -2.98M | -2.8M | -2.39M | -2.19M | -2.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 213k | 467k | 1.24M | 9.01M | 3.31M |
| Operating Income | -22.53M | -28.89M | -39.48M | -29.95M | -14.58M |
| Net Income | -21.43M | -28.71M | -41.88M | -29.93M | -8.24M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.49M | 17.13M | 14.09M | 11.68M | 10.91M |
| Total Liabilities | 2.78M | 3.07M | 2.3M | 1.97M | 3.46M |
| Total Equity | 16.71M | 14.05M | 11.79M | 9.7M | 7.45M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.36M | 45.62M | 68.14M | 34.42M | 17.13M |
| Total Liabilities | 2.27M | 18.27M | 24.15M | 14.82M | 3.07M |
| Total Equity | 44.09M | 27.35M | 43.99M | 19.6M | 14.05M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.07M | -16.44M | -3.84M | -7.4M | -6.21M |
| Investing | 18.66M | 18.66M | N/A | N/A | N/A |
| Financing | 1.1M | 1.11M | 49k | 93k | 96k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.29M | -18.86M | -27.28M | -26.97M | -16.44M |
| Investing | -375k | -10.43M | -3.13M | -4.95M | 18.66M |
| Financing | 817k | 6.74M | 52.56M | 202k | 1.11M |
| Market Cap | 15.97M |
| Price to Earnings Ratio | -1.94 |
| Price to Sales Ratio | 4.82 |
| Price to Cash Ratio | 1.06 |
| Price to Book Ratio | 1.14 |
| Dividend Yield | - |
| Shares Outstanding | 8.92M |
| Average Volume (1 week) | 103.09k |
| Average Volume (1 Month) | 82.28k |
| 52 Week Change | -62.71% |
| 52 Week High | 5.99 |
| 52 Week Low | 1.65 |
| Spread (Intraday) | 0.83 (33.2%) |
| Company Name | Marker Therapeutics Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.markertherapeutics.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
